Key result
Medtronic CoreValve TAVI had a 44% (16/36) rate of third-degree AV block and new pacemaker implantation vs 7% (1/14) with transapical Edwards-Sapien.
Why the study?
Does the Medtronic CoreValve Revalving System increase the risk of atrioventricular conduction abnormalities and new permanent pacemaker implantation compared with the Edwards-Sapien bioprosthesis in patients undergoing transcatheter aortic valve implantation?
Does the Medtronic CoreValve Revalving System increase the risk of atrioventricular conduction abnormalities and new permanent pacemaker implantation compared with the Edwards-Sapien bioprosthesis in patients undergoing transcatheter aortic valve implantation?
Answers are grounded in this paper and cite their sources.
This editorial highlights that while early observational data show higher rates of conduction disturbances and pacemaker implantation with the Medtronic CoreValve (44%) versus the Edwards-Sapien valve (7%), attributing this solely to the device is premature without accounting for procedural factors like implantation depth, sizing, and aortic regurgitation.
This editorial refers to ‘Electrocardiographic and further predictors for permanent pacemaker requirement after transcatheter aortic valve implantation’ by D. Erkapic et al. , on page 1188. Erkapic et al.1 report on the frequency of atrioventricular (AV) conduction abnormalities and new permanent pacemaker (PM) implantation in a series of 50 patients undergoing either Medtronic CoreValve implantation via the femoral artery or the Edwards Sapien valve via a transapical approach. The clinical relevance of this report is related to the fact that conduction abnormalities and implantation of a new PM is currently subject of debate whether this should be considered as a serious adverse event or not. There is a point to do so, since the loss of appropriate conduction and electrical activation of the myocardium in these elderly patients with age-related histological changes in addition to histological changes induced by the increased afterload may affect cardiac output and thus quality of life. Following surgical aortic valve replacement (SAVR), a new onset left bundle branch block (BBB) has been reported in 16–32% of the patients and new PM implantations are performed in 3–8%. 2–5 The close anatomic relationship between the aortic valve complex and the AV and intraventricular conduction tissue may explain the occurrence of the conduction disturbances following valve procedures. 6 Following transcatheter aortic valve implantation (TAVI), a new onset left BBB and PM implantation with the Medtronic CoreValve Revalving System (CRS) have been reported in up to 65 and 30%, respectively. 7–11 Patients treated with the Edwards–Sapien prosthesis are reported to have left BBB and PM implantation in 20 and 10%, respectively. 9 , 12 In a series of 50 patients, Erkapic et al. confirmed that a third-degree AV block and subsequent new PM implantation were more common in patients treated with the CRS (16/36, 44%) compared with those who underwent transapical implantation of the Edwards–Sapien bioprosthesis (1/14, 7%). They report that pre-existing right BBB and CRS are predictors for new onset AV block and PM implantation and, therefore, they conclude that using the Edwards device might be more effective in reducing the risk of PM implantation. These findings and statements need to be interpreted with caution, given the sample size and the complex and multifactorial aetiology of conduction abnormalities during and after TAVI. The only consistency with previous reports which also stem from small-sized single-centre observations is the direction of outcome. This and other studies lack the power and are of insufficient design to adequately interpret the point estimate and the predictive factors of conduction abnormalities. Among others, aetiological factors such as depth of implantation and sizing could not be explored by Erkapic et al. In addition, the authors do not report echo-Doppler cardiographic findings. Aortic regurgitation is a well-established predictor of conduction disturbances after surgical valve implantation. 2 , 4 , 8 This in turn may lead to a higher frequency of conduction abnormalities during the follow-up period as a result of increased stretch on the conduction tissue. In other words, some potential aetiological factors are correctable (such as depth of implantation and correct sizing) while others are not. Despite the consistency of the direction of outcome, it is premature and fallacious to postulate on the basis of an observation in 50 patients that the occurrence of conduction abnormalities is device related. Finally, in the absence of criteria of PM implantation, the reported frequency of PM implantation is difficult to interpret. It is astonishing to see that in the presence of an ever increasing number of TAVI procedures, there is a remarkable absence of in-depth knowledge and understanding of the procedure. 13 Conflict of interest: none declared.
No takes yet. Share an insight, caveat, or question.
Nuis et al. (2010) conducted an editorial in Patients undergoing transcatheter aortic valve implantation (TAVI) (n=50). Medtronic CoreValve Revalving System (CRS) via femoral artery vs. Edwards-Sapien bioprosthesis via transapical approach was evaluated on Third-degree atrioventricular (AV) block and subsequent new permanent pacemaker (PM) implantation. Medtronic CoreValve TAVI had a 44% (16/36) rate of third-degree AV block and new pacemaker implantation vs 7% (1/14) with transapical Edwards-Sapien.
Synapse has enriched 10 related papers. Consider them for comparative context: